276 related articles for article (PubMed ID: 21858188)
1. Trabecular reorganization in consecutive iliac crest biopsies when switching from bisphosphonate to strontium ranelate treatment.
Jobke B; Burghardt AJ; Muche B; Hahn M; Semler J; Amling M; Majumdar S; Busse B
PLoS One; 2011; 6(8):e23638. PubMed ID: 21858188
[TBL] [Abstract][Full Text] [Related]
2. Effects of strontium ranelate administration on bisphosphonate-altered hydroxyapatite: Matrix incorporation of strontium is accompanied by changes in mineralization and microstructure.
Busse B; Jobke B; Hahn M; Priemel M; Niecke M; Seitz S; Zustin J; Semler J; Amling M
Acta Biomater; 2010 Dec; 6(12):4513-21. PubMed ID: 20654744
[TBL] [Abstract][Full Text] [Related]
3. In osteoporotic women treated with strontium ranelate, strontium is located in bone formed during treatment with a maintained degree of mineralization.
Boivin G; Farlay D; Khebbab MT; Jaurand X; Delmas PD; Meunier PJ
Osteoporos Int; 2010 Apr; 21(4):667-77. PubMed ID: 19597910
[TBL] [Abstract][Full Text] [Related]
4. Distribution of strontium and mineralization in iliac bone biopsies from osteoporotic women treated long-term with strontium ranelate.
Doublier A; Farlay D; Khebbab MT; Jaurand X; Meunier PJ; Boivin G
Eur J Endocrinol; 2011 Sep; 165(3):469-76. PubMed ID: 21690207
[TBL] [Abstract][Full Text] [Related]
5. The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.
Middleton ET; Steel SA; Aye M; Doherty SM
J Bone Miner Res; 2010 Mar; 25(3):455-62. PubMed ID: 20201000
[TBL] [Abstract][Full Text] [Related]
6. Impact of treatments for postmenopausal osteoporosis (bisphosphonates, parathyroid hormone, strontium ranelate, and denosumab) on bone quality: a systematic review.
Gallacher SJ; Dixon T
Calcif Tissue Int; 2010 Dec; 87(6):469-84. PubMed ID: 20872215
[TBL] [Abstract][Full Text] [Related]
7. Bone material quality in transiliac bone biopsies of postmenopausal osteoporotic women after 3 years of strontium ranelate treatment.
Roschger P; Manjubala I; Zoeger N; Meirer F; Simon R; Li C; Fratzl-Zelman N; Misof BM; Paschalis EP; Streli C; Fratzl P; Klaushofer K
J Bone Miner Res; 2010 Apr; 25(4):891-900. PubMed ID: 20437609
[TBL] [Abstract][Full Text] [Related]
8. The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years.
Middleton ET; Steel SA; Aye M; Doherty SM
Osteoporos Int; 2012 Jan; 23(1):295-303. PubMed ID: 21274515
[TBL] [Abstract][Full Text] [Related]
9. Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis.
Meunier PJ; Roux C; Ortolani S; Diaz-Curiel M; Compston J; Marquis P; Cormier C; Isaia G; Badurski J; Wark JD; Collette J; Reginster JY
Osteoporos Int; 2009 Oct; 20(10):1663-73. PubMed ID: 19153678
[TBL] [Abstract][Full Text] [Related]
10. Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.
Arlot ME; Jiang Y; Genant HK; Zhao J; Burt-Pichat B; Roux JP; Delmas PD; Meunier PJ
J Bone Miner Res; 2008 Feb; 23(2):215-22. PubMed ID: 17922612
[TBL] [Abstract][Full Text] [Related]
11. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.
Meunier PJ; Roux C; Seeman E; Ortolani S; Badurski JE; Spector TD; Cannata J; Balogh A; Lemmel EM; Pors-Nielsen S; Rizzoli R; Genant HK; Reginster JY
N Engl J Med; 2004 Jan; 350(5):459-68. PubMed ID: 14749454
[TBL] [Abstract][Full Text] [Related]
12. Effects of strontium on the quality of bone apatite crystals: a paired biopsy study in postmenopausal osteoporotic women.
Doublier A; Farlay D; Jaurand X; Vera R; Boivin G
Osteoporos Int; 2013 Mar; 24(3):1079-87. PubMed ID: 23108780
[TBL] [Abstract][Full Text] [Related]
13. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.
Rizzoli R; Chapurlat RD; Laroche JM; Krieg MA; Thomas T; Frieling I; Boutroy S; Laib A; Bock O; Felsenberg D
Osteoporos Int; 2012 Jan; 23(1):305-15. PubMed ID: 21909729
[TBL] [Abstract][Full Text] [Related]
14. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
15. Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis.
Rizzoli R; Laroche M; Krieg MA; Frieling I; Thomas T; Delmas P; Felsenberg D
Rheumatol Int; 2010 Aug; 30(10):1341-8. PubMed ID: 20512336
[TBL] [Abstract][Full Text] [Related]
16. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.
Collette J; Bruyère O; Kaufman JM; Lorenc R; Felsenberg D; Spector TD; Diaz-Curiel M; Boonen S; Reginster JY
Osteoporos Int; 2010 Feb; 21(2):233-41. PubMed ID: 19436941
[TBL] [Abstract][Full Text] [Related]
17. Teriparatide in bisphosphonate-resistant osteoporosis: microarchitectural changes and clinical results after 6 and 18 months.
Jobke B; Muche B; Burghardt AJ; Semler J; Link TM; Majumdar S
Calcif Tissue Int; 2011 Aug; 89(2):130-9. PubMed ID: 21626160
[TBL] [Abstract][Full Text] [Related]
18. Strontium is incorporated into mineral crystals only in newly formed bone during strontium ranelate treatment.
Li C; Paris O; Siegel S; Roschger P; Paschalis EP; Klaushofer K; Fratzl P
J Bone Miner Res; 2010 May; 25(5):968-75. PubMed ID: 19874195
[TBL] [Abstract][Full Text] [Related]
19. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
Reginster JY; Deroisy R; Jupsin I
Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
[TBL] [Abstract][Full Text] [Related]
20. Strontium ranelate improves bone microarchitecture in osteoporosis.
Hamdy NA
Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]